Research News for 2010
-
Women with Family History of Breast Cancer Benefit from Mammograms Starting at 40
A new British study suggests that screening mammograms in women aged 40 to 50 with a family history of breast cancer are beneficial.
-
Halaven Approved by FDA to Treat Metastatic Breast Cancer
The FDA has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemotherapy medicines.
-
Xgeva Slightly Better Than Zometa at Reducing Breast Cancer Bone Complications
Research has found that Xgeva (chemical name: denosumab), a new targeted therapy medicine, is somewhat better than Zometa at lowering the risk of bone complications in women diagnosed with breast cancer that has spread to the bones.
-
Women Happier with Silicone Rather Than Saline Implants
Research suggests women who chose a silicone gel implant were slightly happier with reconstruction after mastectomy compared to women who chose a saline implant.
-
Chemo and Radiation Before Surgery Seems to Reduce Risk of Recurrence for Certain Breast Cancers
Research suggests that giving BOTH chemotherapy and radiation therapy before surgery to remove locally advanced breast cancer can help reduce the risk of the cancer coming back in the breast area in the 5 years after surgery.
-
Experimental Osteoporosis Medicine May Reduce Breast Cancer Risk
An experimental osteoporosis medicine has been shown to reduce the risk of breast cancer in postmenopausal women.
-
Antiperspirants Don’t Increase Risk of Skin Reactions During Radiation Therapy
A small study suggests that using antiperspirant doesn't increase the risk or severity of skin reactions during radiation therapy.
-
Fertility Counseling Before Cancer Treatment Boosts Quality of Life
Research suggests that young women who get fertility counseling before cancer treatment have fewer regrets and better overall quality of life after treatment compared to women who don't get fertility counseling.
-
Children Can Inherit Abnormal Breast Cancer Genes from Father
Research suggests that women are much more likely to be referred for genetic counseling if the family history of breast or ovarian cancer is on their mother's side rather than their father's.
-
Study Reinforces Link Between Breast Cancer Risk and Hormone Replacement Therapy
A new analysis of Women's Health Initiative data shows that women who use combination HRT are nearly twice as likely to die from breast cancer compared to women who don't use HRT.
